Wei-Wu He

CIK 1542073 · Chairman and CEO · last filed 2022-06-17

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

36

Lifetime Open-Market Net

$33.62M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CASI Pharmaceuticals, Inc. (CASI) Delisted Chairman and CEO 894,553 $0.28 $250.5K $33.62M 33 2022-06-17
CASI Pharmaceuticals, Inc. (ENMD) Delisted Director 465,770 $0 3 2013-05-31

Recent Filings · Page 4 of 4

36 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-03-04 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) $0 EDGAR
2015-04-08 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) $0 EDGAR
2014-11-14 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) $0 EDGAR
2013-05-31 CASI Pharmaceuticals, Inc. (ENMD) Delisted Grant (A) $0 EDGAR
2012-05-03 CASI Pharmaceuticals, Inc. (ENMD) Delisted Mixed +441,072 $0 EDGAR
2012-03-02 CASI Pharmaceuticals, Inc. (ENMD) Delisted Grant (A) $0 EDGAR
Showing 3136 of 36
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.